Shares of Solazyme Inc. (NASDAQ:TVIA) shot up 3% during trading on Monday . The stock traded as high as $2.45 and last traded at $2.44, with a volume of 163,514 shares trading hands. The stock had previously closed at $2.37.

The stock’s market capitalization is $208.09 million. The company’s 50 day moving average is $2.40 and its 200 day moving average is $2.05.

Solazyme (NASDAQ:TVIA) last posted its quarterly earnings results on Wednesday, May 4th. The company reported ($0.27) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.02. The business earned $10.90 million during the quarter, compared to the consensus estimate of $11.94 million. During the same period in the prior year, the firm earned ($0.37) earnings per share. The business’s revenue for the quarter was down 13.5% on a year-over-year basis. Analysts anticipate that Solazyme Inc. will post ($1.12) earnings per share for the current year.

In other news, CFO Tyler Painter sold 12,500 shares of the company’s stock in a transaction dated Tuesday, June 7th. The shares were sold at an average price of $2.67, for a total transaction of $33,375.00. Following the completion of the transaction, the chief financial officer now directly owns 400,337 shares of the company’s stock, valued at $1,068,899.79. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.